Next-Gen Test Authorized for Minimal Residual Disease
An estimated 6,000 people in the USA will be diagnosed with acute lymphoblastic leukemia (ALL) and 31,000 people will be diagnosed with multiple myeloma this year.
Latest News
- Detection System Used for Monitoring Small Molecules
- Novel Fecal Biomarker Found for Colorectal Cancer
- Microbiome Alterations Influence Lung Disease Prognosis
- Rapid Test Uses Glow-in-the-Dark Paper
- Individual HPV Types Linked to HIV Infection
- Kidney Function Decline Linked with Inflammatory Marker Levels
- Test Developed for Uterine Infections Impacting Fertility
- Antibiotic-Resistant Mutations Revealed by Sequencing Method
